Onapristone companion diagnostic - Arno Therapeutics

Drug Profile

Onapristone companion diagnostic - Arno Therapeutics

Alternative Names: Activated progestrone receptors diagnostic - Arno Therapeutics; APR diagnostic - Arno Therapeutics

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Arno Therapeutics
  • Class Diagnostic agents
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Endometrial cancer
  • Phase I/II Breast cancer; Ovarian cancer; Prostate cancer; Uterine cancer

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Breast-cancer(Diagnosis) in USA
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Endometrial-cancer(Diagnosis) in USA
  • 09 Dec 2014 Efficacy data in Breast cancer presented at the 37th Annual San Antonion Breast Cancer Symposium (SABCS-2014)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top